Dyne Therapeutics Posts Wider Loss In Q4
(RTTNews) - Dyne Therapeutics, Inc. (DYN) reported a fourth quarter net loss of $112.0 million, or $0.76 per share compared with a net loss of $89.5 million, or $0.88 per share, a year ago. Research...
Nasdaq News: Markets·11h ago